The full report suite on the U.S. market for neurological devices includes cerebrospinal fluid shunts, cerebrospinal fluid external drainage systems, intracranial pressure monitoring devices, detachable coils, liquid embolics, catheters, guidewires, balloon occlusion devices, neurovascular stents and flow diversion stents, spinal cord stimulators, vagus nerve stimulators, sacral nerve stimulators, deep brain stimulators, gastric electric stimulators, neuroendoscopes, stereotactic frames, stereotactic frameless systems, ultrasonic aspirators, aneurysm clips, neurosurgical microscopes, intrathecal pumps and mechanical thrombectomy devices.
Stereotaxy has become the standard of care in neurosurgery therefore the market for stereotactic systems is saturated, limiting growth in market value. Innovative technology and updated features and software will be required to encourage growth. New competitors have entered the neuromodulation market which will drive competitive pressure in technological advancement and pricing. This will have the greatest impact on the spinal cord stimulator and deep brain stimulator markets. One of the major market drivers for neurological devices is the patient and physicians demand for minimally invasive procedures. This has been driving the growth in interventional neuroradiology and neuroendoscopy. This has led to procedural growth in endovascular embolization treatments and a decline in aneurysm clipping procedures treatments. Access devices are becoming increasingly technologically advanced and various embolization devices have been released in recent years. One of the major emerging trends is the growth of mechanical thrombectomy devices for ischemic stroke. These devices extend the window for treatment of patients compared to medical therapy alone and can provide dramatically improved clinical outcomes.
'
TABLE OF CONTENTS I
LIST OF FIGURES IX
LIST OF CHARTS XI
EXECUTIVE SUMMARY 1
U.S. NEUROMODULATION, NEUROVASCULAR, NEUROSURGICAL AND MONITORING DEVICE MARKET OVERVIEW 1
COMPETITIVE ANALYSIS 4
MARKET TRENDS 8
MARKET DEVELOPMENTS 11
PROCEDURE NUMBERS 12
PROCEDURE CODES INVESTIGATED 13
MARKETS INCLUDED 15
KEY REPORT UPDATES 17
VERSION HISTORY 17
RESEARCH METHODOLOGY 18
1.1 RESEARCH SCOPE 18
1.2 IDATA’S 9-STEP METHODOLOGY 18
Step 1: Project Initiation & Team Selection 18
Step 2: Prepare Data Systems and Perform Secondary Research 20
Step 3: Preparation for Interviews & Questionnaire Design 21
Step 4: Performing Primary Research 22
Step 5: Research Analysis: Establishing Baseline Estimates 24
Step 6: Market Forecast and Analysis 25
Step 7: Identify Strategic Opportunities 27
Step 8: Final Review and Market Release 28
Step 9: Customer Feedback and Market Monitoring 29
DISEASE OVERVIEW 30
2.1 BASIC ANATOMY 30
2.2 DISEASE PATHOLOGY AND DISORDERS 32
2.2.1 Introduction 32
2.2.2 General Diagnostics and Neurosurgery 34
2.2.3 Tumor and Brain Cancer 36
2.2.4 Brain Arteriovenous Malformations 38
2.2.5 Ischemic Stroke 39
2.2.6 Brain Aneurysm 40
2.2.7 Disorders Related to Cerebrospinal Fluids and Intracranial Pressure 42
2.2.7.1 Hydrocephalus and Intracranial Pressure Disorder 42
2.2.7.2 Cerebral Edema 43
2.2.8 Indication for Neuromodulation 45
2.2.9 Traumatic brain injury 47
NEUROLOGICAL PROCEDURE NUMBERS 48
3.1 LIST OF PROCEDURAL CODES 48
3.2 PROCEDURE ANALYSIS AND FORECAST 50
3.2.1 Cerebrospinal Fluid Shunting Procedures 50
3.2.2 Neurovascular Embolization Procedures 56
3.2.3 Intracranial Stenting Procedures 58
3.2.4 Neuromodulation Procedures 60
3.2.4.1 Spinal Cord Stimulator Procedures 60
3.2.4.2 Deep Brain Stimulator Procedures 62
3.2.4.3 Peripheral Nerve Stimulator Procedures 64
3.2.5 Aneurysm Clipping Procedures 68
3.2.6 Intrathecal Pump Procedures 70
3.2.7 Intracranial Neuroendoscopic Procedures 72
ABBREVIATIONS 74
APPENDIX II: COMPANY PRESS RELEASES 77
Chart 1 1: Neurological Device Market by Segment, U.S., 2013 – 2023 3
Chart 1 2: Neurological Device Market Overview, U.S., 2016 & 2023 3
Chart 3 1: Cerebrospinal Fluid Shunting Procedures, U.S., 2013 – 2023 51
Chart 3 2: Cerebrospinal Fluid Shunting Procedures, U.S., 2013 – 2023 52
Chart 3 3: Lumbar Shunting Procedures, U.S., 2013 – 2023 54
Chart 3 4: Lumbar Shunting Procedures, U.S., 2013 – 2023 55
Chart 3 5: Neurovascular Embolization Procedures, U.S., 2013 – 2023 57
Chart 3 6: Intracranial Stenting Procedures, U.S., 2013 – 2023 59
Chart 3 7: Spinal Cord Stimulator Implementation Procedures, U.S., 2013 – 2023 61
Chart 3 8: Deep Brain Stimulator Implementation Procedures, U.S., 2013 – 2023 63
Chart 3 9: Peripheral Nerve Stimulator Implementation Procedures, U.S., 2013 – 2023 65
Chart 3 10: Vagus, Sacral and Gastric Nerve Stimulator Implementation Procedures, U.S., 2013 – 2023 67
Chart 3 11: Aneurysm Clipping Procedures, U.S., 2013 – 2023 69
Chart 3 12: Intrathecal Pump Procedures, U.S., 2013 – 2023 71
Chart 3 13: Intracranial Neuroendoscopic Procedures, U.S., 2013 – 2023 73
Figure 1 1: Neurological Device Market Share Ranking by Segment, U.S., 2016 (1 of 3) 5
Figure 1 2: Neurological Device Market Share Ranking by Segment, U.S., 2016 (2 of 3) 5
Figure 1 3: Neurological Device Market Share Ranking by Segment, U.S., 2016 (3 of 3) 6
Figure 1 4: Companies Researched in this Report, U.S., 2016 7
Figure 1 5: Factors Impacting the Neurological Device Market by Segment, U.S. (1 of 3) 8
Figure 1 6: Factors Impacting the Neurological Device Market by Segment, U.S. (2 of 3) 9
Figure 1 7: Factors Impacting the Neurological Device Market by Segment, U.S. (3 of 3) 10
Figure 1 8: Recent Events in the Neurological Device Market, U.S., 2014 – 2016 11
Figure 1 9: Neurological Device Markets Covered, U.S., 2016 12
Figure 1 10: Procedural Codes Investigated, U.S., 2016 (1 of 2) 13
Figure 1 11: Procedural Codes Investigated, U.S., 2016 (2 of 2) 14
Figure 1 12: Neurological Device Markets Covered, U.S., 2016 (1 of 2) 15
Figure 1 13: Neurological Device Markets Covered, U.S., 2016 (2 of 2) 16
Figure 1 14: Key Report Updates 17
Figure 1 15: Version History 17
Figure 2 1: Neurology Disease Overview 33
Figure 2 2: Brain/Other Nervous System Cancer Statistics by Type and Gender, U.S., 2016 37
Figure 3 1: Procedural Codes Investigated, U.S., 2016 (1 of 2) 48
Figure 3 2: Procedural Codes Investigated, U.S., 2016 (2 of 2) 49
Figure 3 3: Cerebrospinal Fluid Shunting Procedures, U.S., 2013 – 2023 50
Figure 3 4: Cerebrospinal Fluid Shunting Procedures, U.S., 2013 – 2023 52
Figure 3 5: Lumbar Shunting Procedures, U.S., 2013 – 2023 53
Figure 3 6: Lumbar Shunting Procedures, U.S., 2013 – 2023 54
Figure 3 7: Neurovascular Embolization Procedures, U.S., 2013 – 2023 56
Figure 3 8: Intracranial Stenting Procedures, U.S., 2013 – 2023 58
Figure 3 9: Spinal Cord Stimulator Implementation Procedures, U.S., 2013 – 2023 60
Figure 3 10: Deep Brain Stimulator Implementation Procedures, U.S., 2013 – 2023 62
Figure 3 11: Peripheral Nerve Stimulator Implementation Procedures, U.S., 2013 – 2023 64
Figure 3 12: Vagus, Sacral and Gastric Nerve Stimulator Implementation Procedures, U.S., 2013 – 2023 66
Figure 3 13: Aneurysm Clipping Procedures, U.S., 2013 – 2023 68
Figure 3 14: Intrathecal Pump Procedures, U.S., 2013 – 2023 70
Figure 3 15: Intracranial Neuroendoscopic Procedures, U.S., 2013 – 2023 72
Figure 5 1: Press Release Summary 77
Medtronic
Boston Scientific
St. Jude Medical
Cyberonics
Codman & Shurtleff
Stryker
Integra LifeSciences
InoMed
Mizuho America
RauMedic
